EARTH SCIENCE TECH INC - ETST STOCK NEWS

Earth Science Tech, Inc. (OTC: ETST) announced its annual financial results for the fiscal year ending March 31, 2024, showcasing significant growth. The company reported $11.95 million in revenue, a remarkable 24,527.88% increase year-over-year (YOY), and a net profit of $812,139 compared to a loss of $365,405 the previous year, marking a 322.26% improvement. The total assets grew by 42.28% to $3.88 million, and cash reserves surged by 1,851.34% to $697,721. The gross profit also saw a substantial rise to $7.83 million, an increase of 35,387.28% YOY. Key operational highlights include the repurchase of 5,200,002 shares, the expansion of office and storage spaces, and enhancement of the Board of Directors with new members and the establishment of an audit committee. Additionally, the company expanded its workforce to 39 employees and 8 independent contractors. RxCompoundStore.com and Peaks Curative, , two of the company's subsidiaries, continue to expand their services and market presence in the health and wellness industry.

Earth Science Tech, Inc. (OTC: ETST) shares an annual letter from the CEO, highlighting significant accomplishments for the fiscal year ending March 31, 2024. The company has made substantial progress in various areas, such as expanding operations, hiring key personnel, repurchasing shares, and achieving impressive revenue growth. These achievements demonstrate management's dedication to shareholder value and strategic growth initiatives.

Earth Science Tech, Inc. (ETST) has announced a $5 million stock repurchase program, authorized by the Board of Directors. The program allows for repurchases on the open market or through privately negotiated transactions, with an expiration date of December 31, 2025. The CEO, Giorgio R. Saumat, emphasizes the commitment to creating shareholder value.

Earth Science Tech, Inc. (OTC: ETST) shares financial results, highlights, and outlook from record fiscal Q2 2023 report. The company recorded significant increases in cash, assets, revenue, gross profit, and net profit compared to the previous year. Liabilities decreased by 54%, and stockholders' equity increased by 13%. The company also highlighted its expansion, new product launches, and plans for diversification and growth.

Earth Science Tech, Inc. announces the launch of DocProtocol.com, a platform that offers patient-specific protocols to doctors and wellness centers. The protocols are developed by functional medicine professionals and are expected to generate sales for two of the company's subsidiaries. DocProtocol makes it easy for healthcare professionals to enter patient data and receive a protocol for treatment. The initial set of protocols includes Weight Loss, Testosterone Therapy, Active Virus Therapy, Immune Booster Therapy, and more. The company plans to monetize this asset by charging a monthly fee to medical professionals and driving prescriptions to RxCompoundStore.

Earth Science Tech, Inc. (OTC: ETST) shares financial results, highlights, and outlook from record fiscal Q1 2023 report. Cash increased by 352.63% to $91,989 compared to last year. Assets increased by 759% to $2,752,719. Revenue was $219,934, a 353.13% increase. Gross profit was $148,769, a 574.38% increase. Liabilities decreased by 44.59% to $1,263,660. Stockholders Equity increased by 175.97% to $1,489,059.

Earth Science Tech, Inc. (ETST) filed its 10-K report for the year ended March 31, 2023, highlighting key achievements and future growth prospects. During fiscal year 2022, the company retired 81% of its liabilities. The company successfully merged with RxCompoundStore, LLC and Peaks Curative, LLC, expanding its product offerings and obtaining dispensing licenses in multiple states. RxCompound's hazardous compounding room and sterile compounding lab began operations, boosting sales. The company also created various sales channels and subsidiaries to diversify its men's health segment. ETST expects significant revenue growth and free cash flow in the current quarter.